21:59:59.471 POST /answers
21:59:59.484   FastAPI arguments
--- patient_context ---
Name: Isaiah Reed
Date of Birth: 1970-03-11
Gender: Male
Prescription: Zepbound 10 mg once weekly for ongoing
Visit Notes:
  - **Patient Name:** Isaiah Reed
**DOB:** 1970-03-11 (Age: 55 years old)
**Gender:** Male
**Visit Date:** 2025-08-15
**Visit Number:** 1 of 2
**Medication:** Zepbound 10 mg, once weekly
**Duration:** Ongoing
**Months on Medication:** N/A (initial consultation)

---

**Vital Signs:**
- **Height:** 5 ft 10 in (178 cm)
- **Weight:** 261 lbs (118.4 kg)
- **BMI:** 37.4 kg/m²
- **BP:** 138/84 mmHg
- **Pulse:** 78 bpm

---

**Assessment:**
Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m²), hypertension, and dyslipidemia. He has made multiple physician-documented weight loss attempts through diet and exercise, with insufficient sustained weight reduction. He does not have diabetes but is at elevated risk given family history. His BMI and comorbid conditions meet the criteria for anti-obesity pharmacotherapy.

---

**Relevant Medical History:**
- Obesity (BMI >35 with comorbidities)
- Hypertension, diagnosed 2017, well controlled on lisinopril 20 mg daily
- Dyslipidemia, diagnosed 2019, on atorvastatin 20 mg daily
- Family history: father with type 2 diabetes mellitus
- No history of type 2 diabetes (last HbA1c 5.7% in May 2025)
- Allergies: NKDA

**History of Present Illness:**
Mr. Reed presents for an initial consultation regarding weight management. He has tried multiple diets (including calorie restriction and low-carbohydrate regimens), as well as several attempts at increasing physical activity, most recently working with a dietitian and joining a gym in January 2025. He reports some short-term weight loss with these interventions (up to 12 lbs), but has not achieved or maintained significant long-term results.

**Plan:**
1. Initiate Zepbound (tirzepatide) 10 mg subcutaneously once weekly.
2. Continue current antihypertensive and statin therapy.
3. Lifestyle counseling: reduced-calorie diet, at least 150 min/week aerobic activity, referral to registered dietitian.
--------------------
--- all_questions ---
[Question(type='text', key='age', content="What is the patient's age in years?", visible_if=None), Question(type='text', key='weight', content="What is the patient's weight (including unit)?", visible_if=None), Question(type='text', key='height', content="What is the patient's height (including unit)?", visible_if=None), Question(type='text', key='bmi', content="What is the patient's body mass index (BMI) in kilograms per square meter (kg/m2)", visible_if=None), Question(type='boolean', key='expedited_review', content='Expedited/Urgent Review Requested', visible_if=None), Question(type='boolean', key='other_weight_loss_meds', content='Will the medication be used concomitantly with any other weight loss medications?', visible_if=None), Question(type='text', key='diagnosis', content='What is the diagnosis for the medication being requested?', visible_if=None), Question(type='boolean', key='continuation', content='Is this a continuation of therapy?', visible_if=None), Question(type='boolean', key='cont_drug_prev_approved', content='Has the requested drug been dispensed at a pharmacy and approved for coverage previously by a prior plan?', visible_if='{continuation} = true'), Question(type='text', key='cont_duration', content='How long has the patient been on the requested medication?', visible_if='{continuation} = true'), Question(type='boolean', key='cont_less_6m', content='Has the patient been on Zepbound therapy for less than 6 months?', visible_if='{continuation} = true'), Question(type='boolean', key='cont_wl_gt5percent', content='Has the patient had a weight loss of more than or equal to 5% of baseline body weight?', visible_if='{continuation} = true'), Question(type='boolean', key='cont_maintain_wl', content='Has the patient been receiving Zepbound therapy for greater than 6 months and is continuing to experience or maintain weight loss?', visible_if='{continuation} = true and {cont_less_6m} = false'), Question(type='boolean', key='cont_adherent_maint_dose', content='Does the patient meet BOTH of the following: \na. Patient has been adherent to 1 month of treatment,\nb. Patient is currently on a maintenance dose of 5 mg–15 mg once weekly?', visible_if='{continuation} = true'), Question(type='boolean', key='cont_positive_response', content='Has the patient had a positive response to treatment or had improvement in symptoms?', visible_if='{continuation} = true'), Question(type='boolean', key='cont_need_assessed', content="Has the patient's need for continued therapy been assessed within the previous year?", visible_if='{continuation} = true'), Question(type='text', key='cont_baseline_weight', content="What is the patient's baseline weight (including unit)?", visible_if='{continuation} = true'), Question(type='text', key='cont_baseline_bmi', content="What is the patient's baseline body mass index (BMI) in kilograms per square meter (kg/m2)?", visible_if='{continuation} = true'), Question(type='boolean', key='cont_bmi_ge30', content='Does the patient have a baseline BMI greater than or equal to 30 kg per square meter?', visible_if='{continuation} = true'), Question(type='boolean', key='cont_bmi_ge27_comorbid', content='Does the patient have a baseline BMI greater than or equal to 27 kg per square meter AND at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes, dyslipidemia)?', visible_if='{continuation} = true'), Question(type='boolean', key='coadmin_tirzepatide', content='Is the requested medication being co-administered with ANY of the following: (1) Tirzepatide-containing products (e.g., Mounjaro), (2) GLP-1 receptor agonists (e.g., Saxenda, Trulicity, Victoza)?', visible_if=None), Question(type='boolean', key='antiobesity_3m_therapy', content='Has the patient completed at least 3 months of therapy at a stable maintenance dose?', visible_if=None), Question(type='boolean', key='antiobesity_wl_gt5percent', content='Has the patient lost at least 5% of baseline body weight or continued to maintain their initial 5% weight loss?', visible_if='{antiobesity_3m_therapy} = true'), Question(type='boolean', key='antiobesity_bmi_ge30', content='Does the patient have a BMI greater than or equal to 30 kg per square meter?', visible_if=None), Question(type='boolean', key='antiobesity_bmi_ge27_comorbid', content='Does the patient have a BMI greater than or equal to 27 kg per square meter AND at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes, dyslipidemia)?', visible_if=None), Question(type='boolean', key='antiobesity_charts_submitted', content="Have chart notes showing the patient's BMI or weight-related comorbid condition been submitted?", visible_if=None), Question(type='boolean', key='antiobesity_wt_mgmt_6m', content='Has the patient participated in a comprehensive weight-management program (diet, exercise, follow-up) for at least 6 months prior to drug therapy?', visible_if=None), Question(type='boolean', key='antiobesity_wt_mgmt_3m', content='Has the patient engaged in a trial of behavioral modification and dietary restriction for at least 3 months?', visible_if='{antiobesity_wt_mgmt_6m} = false'), Question(type='boolean', key='antiobesity_with_diet', content='Will the requested medication be used with a reduced-calorie diet and increased physical activity?', visible_if=None), Question(type='boolean', key='antiobesity_age_12_17', content='Is the patient 12 to 17 years of age with a BMI showing obesity?', visible_if=None)]
--------------------
--- LLM prompt built ---
You are a clinical prior authorization assistant. Answer each question below using ONLY the patient information provided. Be concise and accurate.

PATIENT INFORMATION:
Name: Isaiah Reed
Date of Birth: 1970-03-11
Gender: Male
Prescription: Zepbound 10 mg once weekly for ongoing
Visit Notes:
  - **Patient Name:** Isaiah Reed
**DOB:** 1970-03-11 (Age: 55 years old)
**Gender:** Male
**Visit Date:** 2025-08-15
**Visit Number:** 1 of 2
**Medication:** Zepbound 10 mg, once weekly
**Duration:** Ongoing
**Months on Medication:** N/A (initial consultation)

---

**Vital Signs:**
- **Height:** 5 ft 10 in (178 cm)
- **Weight:** 261 lbs (118.4 kg)
- **BMI:** 37.4 kg/m²
- **BP:** 138/84 mmHg
- **Pulse:** 78 bpm

---

**Assessment:**
Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m²), hypertension, and dyslipidemia. He has made multiple physician-documented weight loss attempts through diet and exercise, with insufficient sustained weight reduction. He does not have diabetes but is at elevated risk given family history. His BMI and comorbid conditions meet the criteria for anti-obesity pharmacotherapy.

---

**Relevant Medical History:**
- Obesity (BMI >35 with comorbidities)
- Hypertension, diagnosed 2017, well controlled on lisinopril 20 mg daily
- Dyslipidemia, diagnosed 2019, on atorvastatin 20 mg daily
- Family history: father with type 2 diabetes mellitus
- No history of type 2 diabetes (last HbA1c 5.7% in May 2025)
- Allergies: NKDA

**History of Present Illness:**
Mr. Reed presents for an initial consultation regarding weight management. He has tried multiple diets (including calorie restriction and low-carbohydrate regimens), as well as several attempts at increasing physical activity, most recently working with a dietitian and joining a gym in January 2025. He reports some short-term weight loss with these interventions (up to 12 lbs), but has not achieved or maintained significant long-term results.

**Plan:**
1. Initiate Zepbound (tirzepatide) 10 mg subcutaneously once weekly.
2. Continue current antihypertensive and statin therapy.
3. Lifestyle counseling: reduced-calorie diet, at least 150 min/week aerobic activity, referral to registered dietitian.

QUESTIONS:
1. key="age" type=text — What is the patient's age in years?
2. key="weight" type=text — What is the patient's weight (including unit)?
3. key="height" type=text — What is the patient's height (including unit)?
4. key="bmi" type=text — What is the patient's body mass index (BMI) in kilograms per square meter (kg/m2)
5. key="expedited_review" type=boolean — Expedited/Urgent Review Requested
6. key="other_weight_loss_meds" type=boolean — Will the medication be used concomitantly with any other weight loss medications?
7. key="diagnosis" type=text — What is the diagnosis for the medication being requested?
8. key="continuation" type=boolean — Is this a continuation of therapy?
9. key="cont_drug_prev_approved" type=boolean — Has the requested drug been dispensed at a pharmacy and approved for coverage previously by a prior plan?
10. key="cont_duration" type=text — How long has the patient been on the requested medication?
11. key="cont_less_6m" type=boolean — Has the patient been on Zepbound therapy for less than 6 months?
12. key="cont_wl_gt5percent" type=boolean — Has the patient had a weight loss of more than or equal to 5% of baseline body weight?
13. key="cont_maintain_wl" type=boolean — Has the patient been receiving Zepbound therapy for greater than 6 months and is continuing to experience or maintain weight loss?
14. key="cont_adherent_maint_dose" type=boolean — Does the patient meet BOTH of the following:
a. Patient has been adherent to 1 month of treatment,
b. Patient is currently on a maintenance dose of 5 mg–15 mg once weekly?
15. key="cont_positive_response" type=boolean — Has the patient had a positive response to treatment or had improvement in symptoms?
16. key="cont_need_assessed" type=boolean — Has the patient's need for continued therapy been assessed within the previous year?
17. key="cont_baseline_weight" type=text — What is the patient's baseline weight (including unit)?
18. key="cont_baseline_bmi" type=text — What is the patient's baseline body mass index (BMI) in kilograms per square meter (kg/m2)?
19. key="cont_bmi_ge30" type=boolean — Does the patient have a baseline BMI greater than or equal to 30 kg per square meter?
20. key="cont_bmi_ge27_comorbid" type=boolean — Does the patient have a baseline BMI greater than or equal to 27 kg per square meter AND at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes, dyslipidemia)?
21. key="coadmin_tirzepatide" type=boolean — Is the requested medication being co-administered with ANY of the following: (1) Tirzepatide-containing products (e.g., Mounjaro), (2) GLP-1 receptor agonists (e.g., Saxenda, Trulicity, Victoza)?
22. key="antiobesity_3m_therapy" type=boolean — Has the patient completed at least 3 months of therapy at a stable maintenance dose?
23. key="antiobesity_wl_gt5percent" type=boolean — Has the patient lost at least 5% of baseline body weight or continued to maintain their initial 5% weight loss?
24. key="antiobesity_bmi_ge30" type=boolean — Does the patient have a BMI greater than or equal to 30 kg per square meter?
25. key="antiobesity_bmi_ge27_comorbid" type=boolean — Does the patient have a BMI greater than or equal to 27 kg per square meter AND at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes, dyslipidemia)?
26. key="antiobesity_charts_submitted" type=boolean — Have chart notes showing the patient's BMI or weight-related comorbid condition been submitted?
27. key="antiobesity_wt_mgmt_6m" type=boolean — Has the patient participated in a comprehensive weight-management program (diet, exercise, follow-up) for at least 6 months prior to drug therapy?
28. key="antiobesity_wt_mgmt_3m" type=boolean — Has the patient engaged in a trial of behavioral modification and dietary restriction for at least 3 months?
29. key="antiobesity_with_diet" type=boolean — Will the requested medication be used with a reduced-calorie diet and increased physical activity?
30. key="antiobesity_age_12_17" type=boolean — Is the patient 12 to 17 years of age with a BMI showing obesity?

Return a JSON object where each key is the question's key and each value is an object with four fields:
  "value": the answer (JSON true/false for boolean, short string for text)
  "confidence": a float from 0.0 to 1.0 indicating how certain you are
    - 1.0 = explicitly stated in the visit note
    - 0.7 = strongly implied by clinical context
    - 0.4 = reasonable inference but not clearly supported
    - 0.1 = not mentioned; guessed from general clinical knowledge
  "reason": a brief (one sentence) explanation of your confidence level
  "citation": the exact phrase or sentence from the visit notes that supports this answer, or null if the answer is inferred from general clinical knowledge

If the information is not available in the patient record, make a reasonable clinical inference.
Answer every question.
--------------------
21:59:59.785     Chat Completion with 'gpt-4o' [LLM]
--- LLM raw response with all answers ---
{
  "age": {
    "value": "55",
    "confidence": 1.0,
    "reason": "The patient's age is explicitly stated in the visit notes.",
    "citation": "DOB: 1970-03-11 (Age: 55 years old)"
  },
  "weight": {
    "value": "261 lbs",
    "confidence": 1.0,
    "reason": "The patient's weight is explicitly stated in the visit notes.",
    "citation": "Weight: 261 lbs (118.4 kg)"
  },
  "height": {
    "value": "5 ft 10 in",
    "confidence": 1.0,
    "reason": "The patient's height is explicitly stated in the visit notes.",
    "citation": "Height: 5 ft 10 in (178 cm)"
  },
  "bmi": {
    "value": "37.4 kg/m\u00b2",
    "confidence": 1.0,
    "reason": "The patient's BMI is explicitly stated in the visit notes.",
    "citation": "BMI: 37.4 kg/m\u00b2"
  },
  "expedited_review": {
    "value": false,
    "confidence": 0.1,
    "reason": "There is no mention of an expedited or urgent review request in the notes.",
    "citation": null
  },
  "other_weight_loss_meds": {
    "value": false,
    "confidence": 0.7,
    "reason": "The plan only mentions initiating Zepbound, with no other weight loss medications listed.",
    "citation": "Plan: 1. Initiate Zepbound (tirzepatide) 10 mg subcutaneously once weekly."
  },
  "diagnosis": {
    "value": "Obesity with comorbid conditions",
    "confidence": 1.0,
    "reason": "The diagnosis is explicitly stated in the assessment.",
    "citation": "Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m\u00b2), hypertension, and dyslipidemia."
  },
  "continuation": {
    "value": false,
    "confidence": 1.0,
    "reason": "This is the initial consultation for the medication.",
    "citation": "Months on Medication: N/A (initial consultation)"
  },
  "cont_drug_prev_approved": {
    "value": false,
    "confidence": 1.0,
    "reason": "The medication has not been dispensed or approved previously.",
    "citation": "Months on Medication: N/A (initial consultation)"
  },
  "cont_duration": {
    "value": "N/A",
    "confidence": 1.0,
    "reason": "The patient has not been on the medication yet.",
    "citation": "Months on Medication: N/A (initial consultation)"
  },
  "cont_less_6m": {
    "value": true,
    "confidence": 1.0,
    "reason": "The patient has not started the medication yet.",
    "citation": "Months on Medication: N/A (initial consultation)"
  },
  "cont_wl_gt5percent": {
    "value": false,
    "confidence": 0.1,
    "reason": "The patient has not started the medication yet, so no weight loss data is available.",
    "citation": null
  },
  "cont_maintain_wl": {
    "value": false,
    "confidence": 1.0,
    "reason": "The patient has not been on the medication for more than 6 months.",
    "citation": "Months on Medication: N/A (initial consultation)"
  },
  "cont_adherent_maint_dose": {
    "value": false,
    "confidence": 1.0,
    "reason": "The patient has not started the medication yet.",
    "citation": "Months on Medication: N/A (initial consultation)"
  },
  "cont_positive_response": {
    "value": false,
    "confidence": 0.1,
    "reason": "The patient has not started the medication yet, so no response data is available.",
    "citation": null
  },
  "cont_need_assessed": {
    "value": true,
    "confidence": 1.0,
    "reason": "The need for therapy was assessed during this initial consultation.",
    "citation": "Plan: 1. Initiate Zepbound (tirzepatide) 10 mg subcutaneously once weekly."
  },
  "cont_baseline_weight": {
    "value": "261 lbs",
    "confidence": 1.0,
    "reason": "The baseline weight is the current weight as the patient has not started the medication.",
    "citation": "Weight: 261 lbs (118.4 kg)"
  },
  "cont_baseline_bmi": {
    "value": "37.4 kg/m\u00b2",
    "confidence": 1.0,
    "reason": "The baseline BMI is the current BMI as the patient has not started the medication.",
    "citation": "BMI: 37.4 kg/m\u00b2"
  },
  "cont_bmi_ge30": {
    "value": true,
    "confidence": 1.0,
    "reason": "The patient's BMI is greater than 30 kg/m\u00b2.",
    "citation": "BMI: 37.4 kg/m\u00b2"
  },
  "cont_bmi_ge27_comorbid": {
    "value": true,
    "confidence": 1.0,
    "reason": "The patient's BMI is greater than 27 kg/m\u00b2 with comorbid conditions.",
    "citation": "Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m\u00b2), hypertension, and dyslipidemia."
  },
  "coadmin_tirzepatide": {
    "value": false,
    "confidence": 0.7,
    "reason": "There is no mention of co-administration with other tirzepatide-containing products or GLP-1 receptor agonists.",
    "citation": "Plan: 1. Initiate Zepbound (tirzepatide) 10 mg subcutaneously once weekly."
  },
  "antiobesity_3m_therapy": {
    "value": false,
    "confidence": 1.0,
    "reason": "The patient has not started the medication yet.",
    "citation": "Months on Medication: N/A (initial consultation)"
  },
  "antiobesity_wl_gt5percent": {
    "value": false,
    "confidence": 0.1,
    "reason": "The patient has not started the medication yet, so no weight loss data is available.",
    "citation": null
  },
  "antiobesity_bmi_ge30": {
    "value": true,
    "confidence": 1.0,
    "reason": "The patient's BMI is greater than 30 kg/m\u00b2.",
    "citation": "BMI: 37.4 kg/m\u00b2"
  },
  "antiobesity_bmi_ge27_comorbid": {
    "value": true,
    "confidence": 1.0,
    "reason": "The patient's BMI is greater than 27 kg/m\u00b2 with comorbid conditions.",
    "citation": "Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m\u00b2), hypertension, and dyslipidemia."
  },
  "antiobesity_charts_submitted": {
    "value": true,
    "confidence": 1.0,
    "reason": "The visit notes provide the necessary information on BMI and comorbid conditions.",
    "citation": "Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m\u00b2), hypertension, and dyslipidemia."
  },
  "antiobesity_wt_mgmt_6m": {
    "value": true,
    "confidence": 0.7,
    "reason": "The patient has been working with a dietitian and joined a gym since January 2025.",
    "citation": "History of Present Illness: ...most recently working with a dietitian and joining a gym in January 2025."
  },
  "antiobesity_wt_mgmt_3m": {
    "value": true,
    "confidence": 1.0,
    "reason": "The patient has engaged in weight management efforts for more than 3 months.",
    "citation": "History of Present Illness: ...most recently working with a dietitian and joining a gym in January 2025."
  },
  "antiobesity_with_diet": {
    "value": true,
    "confidence": 1.0,
    "reason": "The plan includes a reduced-calorie diet and increased physical activity.",
    "citation": "Plan: 3. Lifestyle counseling: reduced-calorie diet, at least 150 min/week aerobic activity, referral to registered dietitian."
  },
  "antiobesity_age_12_17": {
    "value": false,
    "confidence": 1.0,
    "reason": "The patient is 55 years old.",
    "citation": "DOB: 1970-03-11 (Age: 55 years old)"
  }
}
--------------------
--- building response answers base one raw ---
  [1] key='age' value='55' confidence=1.0 citation='DOB: 1970-03-11 (Age: 55 years old)'
{'age': '55'}
  [2] key='weight' value='261 lbs' confidence=1.0 citation='Weight: 261 lbs (118.4 kg)'
{'age': '55', 'weight': '261 lbs'}
  [3] key='height' value='5 ft 10 in' confidence=1.0 citation='Height: 5 ft 10 in (178 cm)'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in'}
  [4] key='bmi' value='37.4 kg/m²' confidence=1.0 citation='BMI: 37.4 kg/m²'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²'}
  [5] key='expedited_review' value=False confidence=0.1 citation=None
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False}
  [6] key='other_weight_loss_meds' value=False confidence=0.7 citation='Plan: 1. Initiate Zepbound (tirzepatide) 10 mg subcutaneously once weekly.'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False}
  [7] key='diagnosis' value='Obesity with comorbid conditions' confidence=1.0 citation='Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m²), hypertension, and dyslipidemia.'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions'}
  [8] key='continuation' value=False confidence=1.0 citation='Months on Medication: N/A (initial consultation)'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions', 'continuation': False}
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_drug_prev_approved' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_duration' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_less_6m' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_wl_gt5percent' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_maintain_wl' (visible_if='{continuation} = true and {cont_less_6m} = false')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_adherent_maint_dose' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_positive_response' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_need_assessed' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_baseline_weight' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_baseline_bmi' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_bmi_ge30' (visible_if='{continuation} = true')
    _evaluate_condition_part: '{continuation} = true' → key='continuation' expected='true' actual=False → False
  SKIP key='cont_bmi_ge27_comorbid' (visible_if='{continuation} = true')
  [9] key='coadmin_tirzepatide' value=False confidence=0.7 citation='Plan: 1. Initiate Zepbound (tirzepatide) 10 mg subcutaneously once weekly.'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions', 'continuation': False, 'coadmin_tirzepatide': False}
  [10] key='antiobesity_3m_therapy' value=False confidence=1.0 citation='Months on Medication: N/A (initial consultation)'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions', 'continuation': False, 'coadmin_tirzepatide': False, 'antiobesity_3m_therapy': False}
    _evaluate_condition_part: '{antiobesity_3m_therapy} = true' → key='antiobesity_3m_therapy' expected='true' actual=False → False
  SKIP key='antiobesity_wl_gt5percent' (visible_if='{antiobesity_3m_therapy} = true')
  [11] key='antiobesity_bmi_ge30' value=True confidence=1.0 citation='BMI: 37.4 kg/m²'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions', 'continuation': False, 'coadmin_tirzepatide': False, 'antiobesity_3m_therapy': False, 'antiobesity_bmi_ge30': True}
  [12] key='antiobesity_bmi_ge27_comorbid' value=True confidence=1.0 citation='Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m²), hypertension, and dyslipidemia.'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions', 'continuation': False, 'coadmin_tirzepatide': False, 'antiobesity_3m_therapy': False, 'antiobesity_bmi_ge30': True, 'antiobesity_bmi_ge27_comorbid': True}
  [13] key='antiobesity_charts_submitted' value=True confidence=1.0 citation='Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m²), hypertension, and dyslipidemia.'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions', 'continuation': False, 'coadmin_tirzepatide': False, 'antiobesity_3m_therapy': False, 'antiobesity_bmi_ge30': True, 'antiobesity_bmi_ge27_comorbid': True, 'antiobesity_charts_submitted': True}
  [14] key='antiobesity_wt_mgmt_6m' value=True confidence=0.7 citation='History of Present Illness: ...most recently working with a dietitian and joining a gym in January 2025.'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions', 'continuation': False, 'coadmin_tirzepatide': False, 'antiobesity_3m_therapy': False, 'antiobesity_bmi_ge30': True, 'antiobesity_bmi_ge27_comorbid': True, 'antiobesity_charts_submitted': True, 'antiobesity_wt_mgmt_6m': True}
    _evaluate_condition_part: '{antiobesity_wt_mgmt_6m} = false' → key='antiobesity_wt_mgmt_6m' expected='false' actual=True → False
  SKIP key='antiobesity_wt_mgmt_3m' (visible_if='{antiobesity_wt_mgmt_6m} = false')
  [15] key='antiobesity_with_diet' value=True confidence=1.0 citation='Plan: 3. Lifestyle counseling: reduced-calorie diet, at least 150 min/week aerobic activity, referral to registered dietitian.'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions', 'continuation': False, 'coadmin_tirzepatide': False, 'antiobesity_3m_therapy': False, 'antiobesity_bmi_ge30': True, 'antiobesity_bmi_ge27_comorbid': True, 'antiobesity_charts_submitted': True, 'antiobesity_wt_mgmt_6m': True, 'antiobesity_with_diet': True}
  [16] key='antiobesity_age_12_17' value=False confidence=1.0 citation='DOB: 1970-03-11 (Age: 55 years old)'
{'age': '55', 'weight': '261 lbs', 'height': '5 ft 10 in', 'bmi': '37.4 kg/m²', 'expedited_review': False, 'other_weight_loss_meds': False, 'diagnosis': 'Obesity with comorbid conditions', 'continuation': False, 'coadmin_tirzepatide': False, 'antiobesity_3m_therapy': False, 'antiobesity_bmi_ge30': True, 'antiobesity_bmi_ge27_comorbid': True, 'antiobesity_charts_submitted': True, 'antiobesity_wt_mgmt_6m': True, 'antiobesity_with_diet': True, 'antiobesity_age_12_17': False}
--- answers ---
[
  {
    "question": {
      "type": "text",
      "key": "age",
      "content": "What is the patient's age in years?",
      "visible_if": null
    },
    "value": "55",
    "confidence": 1.0,
    "confidence_reason": "The patient's age is explicitly stated in the visit notes.",
    "citation": "DOB: 1970-03-11 (Age: 55 years old)"
  },
  {
    "question": {
      "type": "text",
      "key": "weight",
      "content": "What is the patient's weight (including unit)?",
      "visible_if": null
    },
    "value": "261 lbs",
    "confidence": 1.0,
    "confidence_reason": "The patient's weight is explicitly stated in the visit notes.",
    "citation": "Weight: 261 lbs (118.4 kg)"
  },
  {
    "question": {
      "type": "text",
      "key": "height",
      "content": "What is the patient's height (including unit)?",
      "visible_if": null
    },
    "value": "5 ft 10 in",
    "confidence": 1.0,
    "confidence_reason": "The patient's height is explicitly stated in the visit notes.",
    "citation": "Height: 5 ft 10 in (178 cm)"
  },
  {
    "question": {
      "type": "text",
      "key": "bmi",
      "content": "What is the patient's body mass index (BMI) in kilograms per square meter (kg/m2)",
      "visible_if": null
    },
    "value": "37.4 kg/m\u00b2",
    "confidence": 1.0,
    "confidence_reason": "The patient's BMI is explicitly stated in the visit notes.",
    "citation": "BMI: 37.4 kg/m\u00b2"
  },
  {
    "question": {
      "type": "boolean",
      "key": "expedited_review",
      "content": "Expedited/Urgent Review Requested",
      "visible_if": null
    },
    "value": false,
    "confidence": 0.1,
    "confidence_reason": "There is no mention of an expedited or urgent review request in the notes.",
    "citation": null
  },
  {
    "question": {
      "type": "boolean",
      "key": "other_weight_loss_meds",
      "content": "Will the medication be used concomitantly with any other weight loss medications?",
      "visible_if": null
    },
    "value": false,
    "confidence": 0.7,
    "confidence_reason": "The plan only mentions initiating Zepbound, with no other weight loss medications listed.",
    "citation": "Plan: 1. Initiate Zepbound (tirzepatide) 10 mg subcutaneously once weekly."
  },
  {
    "question": {
      "type": "text",
      "key": "diagnosis",
      "content": "What is the diagnosis for the medication being requested?",
      "visible_if": null
    },
    "value": "Obesity with comorbid conditions",
    "confidence": 1.0,
    "confidence_reason": "The diagnosis is explicitly stated in the assessment.",
    "citation": "Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m\u00b2), hypertension, and dyslipidemia."
  },
  {
    "question": {
      "type": "boolean",
      "key": "continuation",
      "content": "Is this a continuation of therapy?",
      "visible_if": null
    },
    "value": false,
    "confidence": 1.0,
    "confidence_reason": "This is the initial consultation for the medication.",
    "citation": "Months on Medication: N/A (initial consultation)"
  },
  {
    "question": {
      "type": "boolean",
      "key": "coadmin_tirzepatide",
      "content": "Is the requested medication being co-administered with ANY of the following: (1) Tirzepatide-containing products (e.g., Mounjaro), (2) GLP-1 receptor agonists (e.g., Saxenda, Trulicity, Victoza)?",
      "visible_if": null
    },
    "value": false,
    "confidence": 0.7,
    "confidence_reason": "There is no mention of co-administration with other tirzepatide-containing products or GLP-1 receptor agonists.",
    "citation": "Plan: 1. Initiate Zepbound (tirzepatide) 10 mg subcutaneously once weekly."
  },
  {
    "question": {
      "type": "boolean",
      "key": "antiobesity_3m_therapy",
      "content": "Has the patient completed at least 3 months of therapy at a stable maintenance dose?",
      "visible_if": null
    },
    "value": false,
    "confidence": 1.0,
    "confidence_reason": "The patient has not started the medication yet.",
    "citation": "Months on Medication: N/A (initial consultation)"
  },
  {
    "question": {
      "type": "boolean",
      "key": "antiobesity_bmi_ge30",
      "content": "Does the patient have a BMI greater than or equal to 30 kg per square meter?",
      "visible_if": null
    },
    "value": true,
    "confidence": 1.0,
    "confidence_reason": "The patient's BMI is greater than 30 kg/m\u00b2.",
    "citation": "BMI: 37.4 kg/m\u00b2"
  },
  {
    "question": {
      "type": "boolean",
      "key": "antiobesity_bmi_ge27_comorbid",
      "content": "Does the patient have a BMI greater than or equal to 27 kg per square meter AND at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes, dyslipidemia)?",
      "visible_if": null
    },
    "value": true,
    "confidence": 1.0,
    "confidence_reason": "The patient's BMI is greater than 27 kg/m\u00b2 with comorbid conditions.",
    "citation": "Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m\u00b2), hypertension, and dyslipidemia."
  },
  {
    "question": {
      "type": "boolean",
      "key": "antiobesity_charts_submitted",
      "content": "Have chart notes showing the patient's BMI or weight-related comorbid condition been submitted?",
      "visible_if": null
    },
    "value": true,
    "confidence": 1.0,
    "confidence_reason": "The visit notes provide the necessary information on BMI and comorbid conditions.",
    "citation": "Assessment: Isaiah is a 55-year-old male with class II obesity (BMI 37.4 kg/m\u00b2), hypertension, and dyslipidemia."
  },
  {
    "question": {
      "type": "boolean",
      "key": "antiobesity_wt_mgmt_6m",
      "content": "Has the patient participated in a comprehensive weight-management program (diet, exercise, follow-up) for at least 6 months prior to drug therapy?",
      "visible_if": null
    },
    "value": true,
    "confidence": 0.7,
    "confidence_reason": "The patient has been working with a dietitian and joined a gym since January 2025.",
    "citation": "History of Present Illness: ...most recently working with a dietitian and joining a gym in January 2025."
  },
  {
    "question": {
      "type": "boolean",
      "key": "antiobesity_with_diet",
      "content": "Will the requested medication be used with a reduced-calorie diet and increased physical activity?",
      "visible_if": null
    },
    "value": true,
    "confidence": 1.0,
    "confidence_reason": "The plan includes a reduced-calorie diet and increased physical activity.",
    "citation": "Plan: 3. Lifestyle counseling: reduced-calorie diet, at least 150 min/week aerobic activity, referral to registered dietitian."
  },
  {
    "question": {
      "type": "boolean",
      "key": "antiobesity_age_12_17",
      "content": "Is the patient 12 to 17 years of age with a BMI showing obesity?",
      "visible_if": null
    },
    "value": false,
    "confidence": 1.0,
    "confidence_reason": "The patient is 55 years old.",
    "citation": "DOB: 1970-03-11 (Age: 55 years old)"
  }
]
INFO:     127.0.0.1:51641 - "POST /answers HTTP/1.1" 200 OK
